Mercer Global Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Buy |
20,723
+2,583
| +14% | +$37.2K | ﹤0.01% | 1820 |
|
|
2025
Q1 | $125K | Buy |
18,140
+8,140
| +81% | +$56.2K | ﹤0.01% | 2033 |
|
|
2024
Q4 | $53.1K | Buy |
+10,000
| New | +$53.1K | ﹤0.01% | 2081 |
|
|
2024
Q2 | – | Sell |
-10,000
| Closed | -$35K | – | 2056 |
|
|
2024
Q1 | $35K | Buy |
+10,000
| New | +$35K | ﹤0.01% | 1907 |
|
|
2023
Q4 | – | Sell |
-10,000
| Closed | -$15K | – | 2102 |
|
|
2023
Q3 | $15K | Buy |
+10,000
| New | +$15K | ﹤0.01% | 1934 |
|